Blog Posts in September, 2011

Metal-on-Metal Hip Implant Failure Rates on the Rise

The National Joint Registry for England and Wales has reported that all metal hips, like DePuy’s ASR, have a higher failure rate than traditional hip replacements. This is data similar to the data ...
Continue Reading +

IMPRELIS: Will the Damaged and Dying Tree Cases be Consolidated?

Tomorrow, the Judicial Panel on Multidistrict Litigation (JPML) will consider consolidation all IMPRELIS® lawsuits into MDL 2284 In Re: IMPRELIS HERBICIDE MARKETING, SALES PRACTICES AND PRODUCTS ...
Continue Reading +

M.D. Anderson Cancer Center

The University of Texas M.D. Anderson Cancer Center was founded in 1941 by the Texas Legislature and is a world leader in the effort to conquer cancer. Their designation as one of the National Cancer ...
Continue Reading +

Regions Morgan Keegan: Paying the Price of Securities Fraud

In June, Regions Morgan Keegan and it senior managers began to understand what price they would pay for their negligence and misrepresentations to investors. The investigation by the Alabama ...
Continue Reading +

IMPRELIS - DuPont's Offer - Enough?

Dupont’s Global Business Leader, Michael McDermott, recently announced a claims resolutions process for golf course superintendents and others who used IMPRELIS® and now have damaged and dying trees. ...
Continue Reading +

Meshing FDA and Manufacturers Together at Transvaginal Mesh Advisory Committee Hearings

On Friday, the U.S. Food and Drug Administration (FDA) Obstetrics & Gynecology Devices Advisory Committee concluded a two-day meeting to review the safety and effectiveness of surgical mesh for ...
Continue Reading +

Poll Indicates F.D.A. Panel Would Recommend Reclassifying Transvaginal Surgical Mesh to Class III Device

On Thursday an informal poll of an F.D.A. advisory panel revealed that the majority of members would favor reclassifying transvaginal surgical mesh products from class II medical devices to class III ...
Continue Reading +

Transvaginal Mesh Manufacturers Tell Advisory Committee They Agree to the Need for More Studies

The Food & Drug Administration (FDA) began Advisory Committee hearings yesterday to address concerns regarding vaginal placement of surgical mesh to treat pelvic organ prolapse and stress urinary ...
Continue Reading +

Fosamax Drug Holidays May Not Be Enough

Per the New York Times , two advisory panels of the F.D.A. will consider the safety of Fosamax and other bisphosphonates which are used to combat osteoporosis and osteopenia. The panels will meet ...
Continue Reading +

Common Issues Persist and Prevail with Zimmer High Flex Knees

On July 28, 2011, the Judicial Panel on Multi-District Litigation held a hearing to determine whether to centralize the lawsuits involving the Zimmer NexGen Knee Implant Products . Centralization ...
Continue Reading +

Transvaginal Mesh is High Risk - FDA Provides Recommendations

Today the FDA advised that transvaginal mesh fails to provide any benefit to women and changed the mesh’s classification to HIGH RISK . In its previous safety alert, the FDA provided guidelines for ...
Continue Reading +